Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2020.00162
Full Text
Open PDFAbstract
Available in full text
Date
February 18, 2020
Authors
Publisher
Frontiers Media SA